Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Intensive Care Medicine|June 28, 2003
The systemic inflammatory response syndrome (SIRS) to identify infected patients in the emergency roomFabián Jaimes, Jenny Garcés, Jorge Cuervo, et al.Investigative Ophthalmology & Visual Science|March 14, 2012
AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseasesJonathan D Oliner, James Bready, Linh Nguyen, et al.Circulation. Cardiovascular Quality and Outcomes|March 5, 2020
Trends in Telestroke Care Delivery: A 15-Year Experience of an Academic Hub and Its Network of SpokesRicha Sharma, Kori S Zachrison, Anand Viswanathan, et al.Arthritis and Rheumatism|October 18, 2002
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritisAngela Coxon, Brad Bolon, Juan Estrada, et al.Journal of Medical Case Reports|July 29, 2023
Unusual presentation of antisynthetase syndrome: a case series and review of the literatureJuan Estrada-Maya, María de Los Ángeles Cuellar, Lina Patricia Vargas, et al.Muscle & Nerve|May 29, 2019
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosisSabrina Paganoni, Marc van de Rijn, Kristin Drake, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|May 18, 2022
Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus MonkeysTod Harper, Amy Sharma, Sarav Kaliyaperumal, et al.Physical Review Letters|May 11, 2019
SENSEI: Direct-Detection Constraints on Sub-GeV Dark Matter from a Shallow Underground Run Using a Prototype Skipper CCDOrr Abramoff, Liron Barak, Itay M Bloch, et al.Cancer Immunology Research|July 3, 2026
Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunityDaniel R Lu, Tao Osgood, Shining Ma, et al.Cancer Research|September 5, 2006
AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenograftsAnthony Polverino, Angela Coxon, Charlie Starnes, et al.Pageof 5